Therefore, this study aimed to analyze perinatal clinical data, serum MED1 and PGC-1α levels and explore their predictive value in BPD to establish a more comprehensive theoretical foundation for early prevention and treatment of BPD. This evidence concerns the gene PPARGC1A and bronchopulmonary dysplasia.